243 related articles for article (PubMed ID: 27754927)
1. Prediagnostic Body Mass Index Trajectories in Relation to Prostate Cancer Incidence and Mortality in the PLCO Cancer Screening Trial.
Kelly SP; Graubard BI; Andreotti G; Younes N; Cleary SD; Cook MB
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 27754927
[TBL] [Abstract][Full Text] [Related]
2. Body mass index trajectories across adulthood and smoking in relation to prostate cancer risks: the NIH-AARP Diet and Health Study.
Kelly SP; Lennon H; Sperrin M; Matthews C; Freedman ND; Albanes D; Leitzmann MF; Renehan AG; Cook MB
Int J Epidemiol; 2019 Apr; 48(2):464-473. PubMed ID: 30376043
[TBL] [Abstract][Full Text] [Related]
3. Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis.
Ma J; Li H; Giovannucci E; Mucci L; Qiu W; Nguyen PL; Gaziano JM; Pollak M; Stampfer MJ
Lancet Oncol; 2008 Nov; 9(11):1039-47. PubMed ID: 18835745
[TBL] [Abstract][Full Text] [Related]
4. Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort.
Zheng R; Du M; Zhang B; Xin J; Chu H; Ni M; Zhang Z; Gu D; Wang M
Br J Cancer; 2018 Jul; 119(1):130-132. PubMed ID: 29872147
[TBL] [Abstract][Full Text] [Related]
5. Body mass index in relation to serum prostate-specific antigen levels and prostate cancer risk.
Bonn SE; Sjölander A; Tillander A; Wiklund F; Grönberg H; Bälter K
Int J Cancer; 2016 Jul; 139(1):50-7. PubMed ID: 26914149
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hoyt M; Song Y; Gao S; O'Palka J; Zhang J
Obesity (Silver Spring); 2022 Nov; 30(11):2275-2285. PubMed ID: 36156459
[TBL] [Abstract][Full Text] [Related]
7. Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies.
Petrick JL; Kelly SP; Liao LM; Freedman ND; Graubard BI; Cook MB
Br J Cancer; 2017 Mar; 116(7):951-959. PubMed ID: 28196067
[TBL] [Abstract][Full Text] [Related]
8. Relationship between male pattern baldness and the risk of aggressive prostate cancer: an analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Zhou CK; Pfeiffer RM; Cleary SD; Hoffman HJ; Levine PH; Chu LW; Hsing AW; Cook MB
J Clin Oncol; 2015 Feb; 33(5):419-25. PubMed ID: 25225425
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
[TBL] [Abstract][Full Text] [Related]
10. Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Hurwitz LM; Dogbe N; Barry KH; Koutros S; Berndt SI
J Natl Cancer Inst; 2023 Dec; 115(12):1506-1514. PubMed ID: 37382561
[TBL] [Abstract][Full Text] [Related]
11. Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.
Möller E; Wilson KM; Batista JL; Mucci LA; Bälter K; Giovannucci E
Int J Cancer; 2016 Feb; 138(4):853-65. PubMed ID: 26355806
[TBL] [Abstract][Full Text] [Related]
12. Body mass index trajectories and prostate cancer risk: Results from the EPICAP study.
Lavalette C; Cordina Duverger E; Artaud F; Rébillard X; Lamy PJ; Trétarre B; Cénée S; Menegaux F
Cancer Med; 2020 Sep; 9(17):6421-6429. PubMed ID: 32639678
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Leitzmann MF; Ahn J; Albanes D; Hsing AW; Schatzkin A; Chang SC; Huang WY; Weiss JM; Danforth KN; Grubb RL; Andriole GL;
Cancer Causes Control; 2008 Dec; 19(10):1267-76. PubMed ID: 18618278
[TBL] [Abstract][Full Text] [Related]
14. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Kitahara CM; Berndt SI; de González AB; Coleman HG; Schoen RE; Hayes RB; Huang WY
J Clin Oncol; 2013 Jul; 31(19):2450-9. PubMed ID: 23715565
[TBL] [Abstract][Full Text] [Related]
15. Relationship between prediagnostic body mass index trajectory and colorectal adenomas: an analysis of the PLCO cancer screening trial.
Luo L; Liu Y; Wang Z; Yan Y; Xie C; Chi J; Yang Y; Li J; Xu R
Ann Transl Med; 2020 Jul; 8(13):815. PubMed ID: 32793660
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Body Mass Index in Early and Middle Adulthood and Estimated Risk of Gastrointestinal Cancer.
Loomans-Kropp HA; Umar A
JAMA Netw Open; 2023 May; 6(5):e2310002. PubMed ID: 37163267
[TBL] [Abstract][Full Text] [Related]
17. Tall height and obesity are associated with an increased risk of aggressive prostate cancer: results from the EPIC cohort study.
Perez-Cornago A; Appleby PN; Pischon T; Tsilidis KK; Tjønneland A; Olsen A; Overvad K; Kaaks R; Kühn T; Boeing H; Steffen A; Trichopoulou A; Lagiou P; Kritikou M; Krogh V; Palli D; Sacerdote C; Tumino R; Bueno-de-Mesquita HB; Agudo A; Larrañaga N; Molina-Portillo E; Barricarte A; Chirlaque MD; Quirós JR; Stattin P; Häggström C; Wareham N; Khaw KT; Schmidt JA; Gunter M; Freisling H; Aune D; Ward H; Riboli E; Key TJ; Travis RC
BMC Med; 2017 Jul; 15(1):115. PubMed ID: 28701188
[TBL] [Abstract][Full Text] [Related]
18. Association of Aspirin Use With Mortality Risk Among Older Adult Participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Loomans-Kropp HA; Pinsky P; Cao Y; Chan AT; Umar A
JAMA Netw Open; 2019 Dec; 2(12):e1916729. PubMed ID: 31800071
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality.
Wright ME; Chang SC; Schatzkin A; Albanes D; Kipnis V; Mouw T; Hurwitz P; Hollenbeck A; Leitzmann MF
Cancer; 2007 Feb; 109(4):675-84. PubMed ID: 17211863
[TBL] [Abstract][Full Text] [Related]
20. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
